Barclays’s Radius Health, Inc. RDUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-113,245
| Closed | -$1.17M | – | 5348 |
|
|
2022
Q2 | $1.17M | Sell |
113,245
-1,471
| -1% | -$10.9K | ﹤0.01% | 2222 |
|
|
2022
Q1 | $1.01M | Buy |
114,716
+37,893
| +49% | +$287K | ﹤0.01% | 2386 |
|
|
2021
Q4 | $532K | Buy |
76,823
+19,923
| +35% | +$292K | ﹤0.01% | 3180 |
|
|
2021
Q3 | $706K | Buy |
56,900
+21,702
| +62% | +$313K | ﹤0.01% | 2993 |
|
|
2021
Q2 | $642K | Sell |
35,198
-67,276
| -66% | -$1.34M | ﹤0.01% | 2929 |
|
|
2021
Q1 | $2.14M | Buy |
102,474
+71,762
| +234% | +$1.51M | ﹤0.01% | 2211 |
|
|
2020
Q4 | $548K | Sell |
30,712
-15,074
| -33% | -$226K | ﹤0.01% | 3184 |
|
|
2020
Q3 | $520K | Sell |
45,786
-14,230
| -24% | -$176K | ﹤0.01% | 3208 |
|
|
2020
Q2 | $818K | Buy |
60,016
+17,661
| +42% | +$243K | ﹤0.01% | 2940 |
|
|
2020
Q1 | $550K | Sell |
42,355
-73,006
| -63% | -$1.3M | ﹤0.01% | 3506 |
|
|
2019
Q4 | $2.33M | Buy |
115,361
+2,927
| +3% | +$71.1K | ﹤0.01% | 2838 |
|
|
2019
Q3 | $2.9M | Buy |
112,434
+49,998
| +80% | +$1.23M | ﹤0.01% | 2424 |
|
|
2019
Q2 | $1.52M | Buy |
62,436
+11,300
| +22% | +$247K | ﹤0.01% | 3227 |
|
|
2019
Q1 | $1.02M | Sell |
51,136
-26,448
| -34% | -$482K | ﹤0.01% | 3380 |
|
|
2018
Q4 | $1.28M | Buy |
77,584
+9,855
| +15% | +$166K | ﹤0.01% | 2867 |
|
|
2018
Q3 | $1.21M | Buy |
67,729
+38,349
| +131% | +$868K | ﹤0.01% | 3455 |
|
|
2018
Q2 | $867K | Buy |
29,380
+12,042
| +69% | +$380K | ﹤0.01% | 3443 |
|
|
2018
Q1 | $623K | Buy |
17,338
+4,919
| +40% | +$178K | ﹤0.01% | 3737 |
|
|
2017
Q4 | $395K | Buy |
12,419
+7,737
| +165% | +$243K | ﹤0.01% | 4088 |
|
|
2017
Q3 | $180K | Sell |
4,682
-9,049
| -66% | -$355K | ﹤0.01% | 4516 |
|
|
2017
Q2 | $621K | Buy |
13,731
+10,066
| +275% | +$385K | ﹤0.01% | 3312 |
|
|
2017
Q1 | $142K | Sell |
3,665
-5,225
| -59% | -$219K | ﹤0.01% | 4616 |
|
|
2016
Q4 | $339K | Buy |
8,890
+5,791
| +187% | +$276K | ﹤0.01% | 3725 |
|
|
2016
Q3 | $167K | Sell |
3,099
-125
| -4% | -$6.35K | ﹤0.01% | 4118 |
|
|
2016
Q2 | $119K | Sell |
3,224
-1,539
| -32% | -$54.3K | ﹤0.01% | 4285 |
|
|
2016
Q1 | $148K | Sell |
4,763
-1,862
| -28% | -$64.4K | ﹤0.01% | 4075 |
|
|
2015
Q4 | $405K | Sell |
6,625
-5,058
| -43% | -$319K | ﹤0.01% | 3367 |
|
|
2015
Q3 | $806K | Buy |
11,683
+11,075
| +1,822% | +$769K | ﹤0.01% | 2935 |
|
|
2015
Q2 | $40K | Sell |
608
-121
| -17% | -$5.64K | ﹤0.01% | 5290 |
|
|
2015
Q1 | $30K | Buy |
729
+288
| +65% | +$12.9K | ﹤0.01% | 5619 |
|
|
2014
Q4 | $17K | Buy |
+441
| New | +$10.5K | ﹤0.01% | 6419 |
|
Other funds holding RDUS
Barclays's RDUS Position: Q3 2022 in Review
Barclays sold out of Radius Health, Inc. (RDUS) in Q3 2022, closing a stake of 113,245 shares — an estimated $1.17M sold.
Barclays first reported a position in RDUS in Q4 2014 and held it in 31 quarters. The position peaked at $2.9M in Q3 2019. 1 fund tracked by Wall St. Rank holds RDUS as of Q3 2022.
- Barclays reported no remaining Radius Health, Inc. position as of Q3 2022 after selling out during the quarter.
- Barclays sold 113,245 Radius Health, Inc. shares in Q3 2022, an estimated $1.17M.
- Barclays first reported a position in Radius Health, Inc. in Q4 2014 and held it in 31 quarters.
- Barclays's Radius Health, Inc. position peaked at $2.9M in Q3 2019.
- 1 fund tracked by Wall St. Rank held Radius Health, Inc. as of Q3 2022.
Based on Barclays's 13F filing for Q3 2022, filed 3 Nov 2022.